WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Ownership - Who owns Jazz Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Jazz Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bruce C. CozaddDirector2025-10-033,500$140.00
$490.00kSell
Bruce C. CozaddDirector2025-10-012,000$131.78
$263.56kSell
Bruce C. CozaddDirector2025-09-1415,647$126.16
$1.97MSell
Bruce C. CozaddDirector2025-09-023,000$127.23
$381.69kSell
Bruce C. CozaddDirector2025-09-023,000$130.00
$390.00kSell
Anne OriordanDirector2025-08-081,805$111.25
$200.80kSell
Kenneth W. OkeefeDirector2025-08-081,805$111.25
$200.81kSell
Mark Douglas SmithDirector2025-08-081,805$111.25
$200.81kSell
Rick E. WinninghamDirector2025-08-081,805$111.25
$200.81kSell
Heather Ann McSharryDirector2025-08-081,959$111.25
$217.94kSell

1 of 6

JAZZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JAZZ insiders and whales buy or sell their stock.

JAZZ Shareholders

What type of owners hold Jazz Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP50.33%30,583,176$4.10BInsider
Kkr Jp III LLC33.04%20,078,838$2.69BInsider
Michael W. Michelson30.56%18,571,250$2.49BInsider
Paul E. Raether30.54%18,557,365$2.49BInsider
Kkr Jp LLC30.54%18,557,365$2.49BInsider
Kkr Group Holdings LP16.36%9,942,946$1.33BInsider
William J. Janetschek14.12%8,577,974$1.15BInsider
Kenneth W. Okeefe10.65%6,472,300$867.61MInsider
Vanguard Group Inc10.02%6,090,872$816.48MInstitution
Bryan C. Cressey9.70%5,894,549$790.16MInsider

1 of 3

JAZZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JAZZ28.85%71.15%Net SellingNet Selling
HALO77.24%22.76%Net SellingNet Selling
RNA88.73%11.27%Net SellingNet Selling
MTSR46.91%53.09%Net BuyingNet Selling
CORT28.94%71.06%Net SellingNet Selling
View Top Biotech Stocks

Jazz Pharmaceuticals Stock Ownership FAQ

Who owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals (NASDAQ: JAZZ) is owned by 101.75% institutional shareholders, 250.99% Jazz Pharmaceuticals insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Jazz Pharmaceuticals shareholder, owning 30.58M shares representing 50.33% of the company. Kkr Group Partnership LP's Jazz Pharmaceuticals shares are currently valued at $4.10B.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.